-
CRISPR/Cas9 Targeting of VZV ORF62/71
2026-08-12
Wu and colleagues developed an AAV-delivered Staphylococcus aureus CRISPR/Cas9 system directed against the duplicated VZV ORF62/71 loci. The approach reduced viral progeny production and cell-to-cell spread in epithelial cells and human neuron cultures, including models of latent infection followed by reactivation, supporting genome editing as a preclinical strategy for limiting VZV replication.
-
Sodium Oxamate and the Lactate Signaling Axis
2026-08-11
Sodium Oxamate is more than a glycolytic research reagent: it is a strategic probe for separating lactate production, redox balance, and lactate-driven signaling. This thought-leadership article examines how LDH-A inhibition can inform cancer metabolism research, tumor bioenergetics studies, and translational work on tissue repair. Findings from a 2026 intracerebral hemorrhage study reveal why metabolic intervention should be interpreted alongside cell-state, epigenetic, and functional endpoints.
-
CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia
2026-08-11
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cell-based experiments place ATP, PKC, ERK1/2, and p38 MAPK upstream of mechanosensory sensitization, providing a mechanistic framework for future trigeminal neuralgia research.
-
Pravastatin sodium: Assay Workflow & Troubleshooting
2026-08-10
Pravastatin sodium provides a practical way to model cholesterol biosynthesis inhibition, LDL handling, and hepatocyte transporter effects in one experimental framework. This guide combines product-backed assay parameters with lessons from a recent human-hepatocyte botanical safety study to improve controls, endpoint selection, and troubleshooting.
-
Topotecan (SKF104864) Research Workflows
2026-08-09
Topotecan (SKF104864) connects topoisomerase I inhibition with practical assays for replication stress, apoptosis, and cell-cycle effects. This guide outlines reproducible workflows for glioma, glioma stem-cell, and pediatric tumor models while separating preclinical assay strategy from clinical context.
-
Epoxomicin for Reliable Cell Assay Design
2026-08-08
Learn how Epoxomicin (SKU A2606) can clarify proteasome-dependent effects in cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers mechanism, solvent compatibility, handling, interpretation, and practical product-selection criteria supported by product data and published research.
-
Reelin-SFK Signaling in Ketamine Antidepressant Action
2026-08-07
The reference study identifies Reelin-Apoer2-Src family kinase signaling as a permissive requirement for ketamine-induced hippocampal plasticity and antidepressant-like behavioral effects. Its combination of genetic models, pathway pharmacology, and electrophysiology suggests that impaired baseline NMDA receptor function may contribute to ketamine nonresponse.
-
Isorhamnetin Enhances Oocyte Maturation via PI3K/Akt Activat
2026-08-07
This study reveals that isorhamnetin, a dietary flavonoid, significantly improves in vitro oocyte maturation by activating the PI3K/Akt pathway, reducing oxidative and endoplasmic reticulum stress, and suppressing apoptosis. These findings provide mechanistic insight and practical parameters for using isorhamnetin in reproductive biology and cellular stress research.
-
Baicalin: Redefining Adult Neuroplasticity and Translational
2026-08-06
This thought-leadership article examines the mechanistic and translational advances enabled by Baicalin—a high-purity flavone glycoside from Scutellaria baicalensis, verified by APExBIO—in restoring neuroplasticity in adult amblyopia and modulating pivotal cancer pathways. By connecting mechanistic insights, rigorous experimental validation, and strategic guidance, this piece challenges conventional limitations and provides translational researchers with actionable protocols and a critical outlook on Baicalin's disruptive potential.
-
Tariquidar (XR9576): Mechanobiology, Chemoresistance, and Ad
2026-08-06
Discover how Tariquidar (XR9576) empowers next-generation drug resistance research by bridging mechanobiology and transporter inhibition. Explore unique insights into mechanical microenvironment-driven chemoresistance and actionable design strategies for advanced assays.
-
Temafloxacin: Pharmacokinetics and Translational Impact in A
2026-08-05
Discover the distinct pharmacokinetic profile of Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, and how this shapes modern antibacterial assay design and translational research. This in-depth review uniquely connects pharmacokinetics to experimental outcomes, providing actionable insights for advanced infection models.
-
Tacalcitol Enhances 5-FU Sensitivity in Colorectal Cancer Ce
2026-08-05
This article reviews recent findings that the vitamin D analog tacalcitol (PRI-2191) increases the effectiveness of 5-fluorouracil (5-FU) chemotherapy in colorectal cancer cells by downregulating thymidylate synthase. The study provides mechanistic insight into how tacalcitol acts through the vitamin D receptor to potentiate 5-FU’s anticancer activity, with implications for future combination therapies.
-
MK-0812: Precision in Monocyte Trafficking Inhibition for MA
2026-08-04
MK-0812 empowers researchers to dissect monocyte-driven inflammation in MASH, providing high potency and selectivity for CCR2 blockade. Its robust performance in both in vitro and in vivo workflows makes it the go-to tool for gut–liver axis and metabolic liver disease studies.
-
SmD2 Acetylation Regulates PARP Inhibitor Sensitivity in HCC
2026-08-04
This study reveals that acetylation of the spliceosome core protein SmD2 modulates DNA repair and sensitivity to PARP inhibitors in hepatocellular carcinoma (HCC). By delineating the interplay between spliceosome regulation and DNA damage response, the research suggests new therapeutic strategies for BRCA-proficient tumors.
-
Galectin-1–FIP200 Axis Impairs Autophagy in Hepatic Steatosi
2026-08-03
This study uncovers a direct mechanistic link between galectin-1 overexpression and impaired hepatic autophagy, revealing that galectin-1 exacerbates hepatic steatosis and insulin resistance by disrupting FIP200 function. These findings highlight the galectin-1–FIP200 pathway as a novel target for metabolic liver disease research and provide a foundation for future therapeutic exploration.